The BAFF/BLyS pathway is particularly noteworthy, as elevated BAFF levels are found in systemic sclerosis-ILD patients and are correlated with more severe lung fibrosis and reduced survival [149]. This evidence concerns the gene TNFSF13B and interstitial lung disease.